References
- Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995; 28(3):173–7
- Smits JPhH, Schop C, Blok G. A comparative study between two insulin pen injection devices. Acta Therapeutica 1993; 19:15–22
- Bohannon NJV, Jack DB. Type II diabetes: tips for managing your older patients. Geriatrics 1996; 51(3):28–35
- Mey A, Gille Y, Thivolet CH. Carriage of staphylococcus aureus and local infections in diabetic outpatients treated with insulin pen. (Letter) Diabetes Care 1990; 13(4):451–2
- Le Floch JP, Herbreteau C, Lange F, et al. Biologie material in needles and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care 1998; 21 (9): 1502–4
- Jefferson IG, Marteau TM, Smith MA, et al. A multiple injection regimen using an insulin injection pen and pre-filled cartridged soluble human insulin in adolescents with diabetes. Diabet Med 1985; 2(2):493–7
- Plevin S, Sadur C. Use of a prefilled insulin syringe (Novolin Prefilled) by patients with diabetes. Clin Ther 1993; 15(2):423–31
- Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998; 20(3): 486–96
- Davidson JA, Roberts VL. Gestational diabetes: ensuring a successful outcome. Postgrad Med 1996; 99(3): 165–72
- American Diabetes Association: Position statement. Insulin administration. Diabetes Care 1997; 20(Suppl 1):S46–9
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977–86
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131):837–53